Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 12 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
These Are the 2 Most Common Symptoms of the New FLiRT COVID Variant Doctors Are Seeing Right Now
Parade· 1 day agoDespite its (admittedly) funny name, you should watch out for these COVID symptoms. According to...
2024 Big 12 softball: Bracket, schedule, scores, TV times for the tournament
NCAA· 9 hours agoThe 2024 Big 12 softball bracket, schedule and scores for the conference tournament, played May 8-11...
There's a new COVID-19 variant called FLiRT: Here's what you need to know about it
USA Today· 4 days agoA new set of COVID-19 variants, nicknamed FLiRT, has been detected in wastewater surveillance,...
COVID-19: What to know about the new variants; what are the symptoms of FLiRT?
FOX 25 Boston· 5 days agoA new group of COVID-19 variants are sparking concerns about a potential flare-up of the virus over...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 3 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
CoreCivic, Inc. (NYSE:CXW) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 14 hours agoCoreCivic, Inc. (NYSE:CXW) Q1 2024 Earnings Call Transcript May 9, 2024 CoreCivic, Inc. isn’t one of...
Reclaiming The Fire in Your Belly | Navigating the challenges of female leadership
WFLA· 2 days agoBLOOM (TAMPA) – In the wake of the COVID-19 pandemic, female leaders are facing unprecedented...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 19 hours agoA full transcript of today’s hearing will be available on the website shortly with an accessible...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
NBC 17 Raleigh· 1 day agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19